That is very important, since the method a protein in the body folds identifies if a pharmaceutical will be able to bind to that protein and work. Simply put, we have to know how these proteins fold if we want a drug to work. Historically, this has actually been an experimental procedure (social media). Now, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it much easier to produce drugs that do what they're created to do. This was an advancement almost nobody discovered. But it's going to have extensive implications for curing illness. I predict that Alpha, Fold will be 98% precise by the end of 2021.
And, of course, there will be lots of financial investment opportunities in this area, too. Moving topics It's going to be an excellent year for bitcoin. I'm bullish on it in 2021 (last week). That stated, I still believe bitcoin will continue to be volatile. We're close to all-time highs. I would not be shocked if it drew back maybe significantly prior to going higher - united states. I have actually been covering bitcoin for a very long time now. Among the very first research study reports I ever released was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that initial recommendation, I entitled my report "What's the Big Deal With Bitcoin?" That shows you where the conversation was at the time. We were mainly educating readers. However that's not the big question any longer. Now we're seeing institutional cash finally take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, specific niche business. Mass, Mutual is a relied on 170-year-old institution. So think of that. In five years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
Which's a big reason I'm bullish on it this year. the legacy report predictions. Regards, Jeff Brown, Editor, The Bleeding Edge I have a bonus prediction 2020 was a record year for IPOs. 552 U.S. business went public the most in more than twenty years. These business raised an overall of $172 billion. That's an all-time high beating the previous annual record by 43%. I forecast 2021 will be another record year in IPOs. There are many fantastic private business on the edge of striking the general public markets And I have actually been dealing with a new method for you to invest even before these business go public.
This chance has actually been constructing over the last couple of years. I can't wait to inform you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to learn all the details. Go right here to reserve your spot free of charge.
Emma Walsh here, handling editor of the Journal. Routine Journal readers understand that tech isn't our usual beat (biotech stocks jeff brown). And when it comes to tech investing, we leave it to the specialists. The good news is, we have several such specialists in our Rolodex. Our coworker Jeff Brown will recognize to our long time readers. He is one of the most accomplished tech investing experts we understand (jeff brown stock predictions). In fact, he had a number of triple-digit returns in his Brownstone Research portfolios last year. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to take a look at the big image and predict what's just around the corner.
That includes things like 5G networks, biotech, artificial intelligence, and a lot more. These patterns are experiencing rapid growth and developing extraordinary opportunities for financiers. I wish to make certain all our readers are prepared for what's next. And with that in mind, let me draw the photo of what I see being available in the next 12 months Our brand-new 5G (fifth-generation) wireless networks are a subject I've been covering for years now. what is the legacy report predicting. But regardless of what many readers may believe, this is a trend that's just getting going. Even though the COVID-19 pandemic disrupted supply chains in 2015, a remarkable 250 million 5G-enabled gadgets were still sold.
And all of this eventually caused Apple delaying the release of the 5G-enabled i, Phone 12 by two months (jeff brown investor prediction). Losing two months of manufacturing and sales really impacts how lots of 5G devices are sold in the calendar year. When you think about all of that, selling 250 million units is impressive. More importantly, the delays brought on by the pandemic created a load of pent-up demand. And that need is now going to be pushed into 2021. In truth, I predict that more than 500 million 5G devices will be shipped in 2021 - first lady. And that's not my only 5G forecast When I've talked about 5G in the past, I have actually explained its three various stages.
In Stage Two, 5G gadgets go on sale. 5G phones and other items begin to reach customers. And in Stage 3, 5G services begin to be used (biotech stock). That's when we start to see applications working on 5G networks. Believe of things like huge multiplayer games over a mobile phone. That's not possible with 4G. It will be with 5G. And my second 5G prediction for 2021 is that we will begin Stage Three by this summertime. This starts something of a virtuous cycle: The majority of people don't actually care about the technology. However they will care if there are interesting applications that can just be accessed with a 5G phone.
That leads to more 5G apps being developed. In fact, 5G is going to open up a suite of unbelievable applications: self-driving vehicles, the Internet of Things, robotic surgery, and more. All of these innovations require 5G. The financial investment chances going forward will be massive. Stepping far from 5G, the next essential innovation I predict in 2021 is CRISPR genetic editing. CRISPR stands for "clustered regularly interspaced brief palindromic repeat." It's a mouthful. But it's one of the most amazing advancements in biotechnology. At a high level, CRISPR is an innovation that can modify our hereditary makeup as if it were software application.
The program can crash or not operate properly. CRISPR uses a comparable concept but with our hereditary code. "Typos" in our genome can result in disease. CRISPR can correct these "typos." For many years, CRISPR was mostly a niche innovation that wasn't well understood. And throughout that time, there were actually only 3 business operating in this area. But things are changing. CRISPR is no longer simply theoretical. We're seeing actual outcomes. We're treating illness and seeing that this technology simply works. And as an outcome, a "second crop" of early-stage CRISPR companies is going public and providing amazing returns. This whole market is effectively a greenfield chance.
There's room for many companies to exist in this space. korean actress. And there will be more. That's my forecast for CRISPR in 2021. I predict that 2 or 3 more genetic modifying companies will hold their IPOs. Sticking with biotechnology, we are seeing remarkable things happening at the convergence of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, simply announced at the end of 2020 that its most current Alpha, Fold software can precisely predict the folding of a protein based exclusively on its amino acid series with 92. 4% accuracy. That is essential due to the fact that the method a protein in the human body folds figures out if a pharmaceutical will have the ability to bind to that protein and be efficient.
Historically, this has actually been an experimental procedure. Today, Alpha, Fold can predict protein folding with 92. 4% precision. That's going to make it much easier to create drugs that do what they're designed to do. And here's my next prediction. I anticipate that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not just one however several drug treatments produced using this technology. This was among those breakthroughs that practically no one observed. However it's going to have profound implications for curing illness. And, obviously, there will be a lot of investment chances in this area, too.
It's going to be a great year for bitcoin. I'm bullish on it in 2021. That said, I still think bitcoin will continue to be unpredictable. We're close to all-time highs. I wouldn't be amazed if it drew back possibly substantially before going higher. I've been covering bitcoin for a very long time now. One of the first research study reports I ever released was on bitcoin - jeff brown prediction. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for anybody who followed my suggestion. However at the time of that preliminary suggestion, I entitled my report, "What's the Big Deal With Bitcoin?" That shows you where the discussion was at the time.
However no one is asking that concern anymore. Now, we're seeing institutional cash lastly taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, specific niche business. exponential tech investor. Mass, Mutual is a 150-year-old organization. So think of that. In five years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a huge reason I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more reward forecast In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown is worth about $27. 5 million and declares the details is up to date as of February 2021, however we might not independently confirm this claim. Given Jeff Brown's past, he likely has a significant net worth, however we can't hammer down a precise figure at this minute. Brown is best known for his sage-like capability to choose winning innovation stocks. He invested more than 25 years researching innovation business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's extensive experience gives him an exceptional point of view on the marketplace. He's constantly on the hunt for new chances, and he shares a lot of his finest choices in the Future Report.
That's high appreciation, however it's not absurdly reasoned. Brown has an outstanding credibility as a stock-picker, and he successfully forecasted some of the biggest economic events of the previous twenty years. Although he does not appear to launch his picks to the general public, the service's success is a direct indicator of Brown's stock-picking prowess. Nobody on Wall Street gets it right every time, however Jeff Brown's precise forecasts have made him legions of devoted fans. That states a lot about his capability. The Future Report is released by Brownstone Research study, a popular financial research publisher. Brownstone Research provides a number of research services with a wide array of specializations - biotech stocks jeff brown.
The business is likewise connected with Bonner & Partners, another well-respected research study publisher - jeff brown genome sequencing. On its site, Brownstone states its mission is to provide retail financiers with professional-grade research study: "For too long, the best financial investment research has actually not been available to specific financiers. It has actually been typically reserved for financial investment banks, hedge funds, personal equity, and high-net-worth customers. diplomatic relations. The mission of Brownstone Research is to make that kind of exclusive research readily available to any investors looking to gain an edge in the markets. The goal is easy to deliver unique and rewarding investment research discovered nowhere else." -Brownstone Research website excerpt from the Jeff Brown is the founder of Brownstone Research, and he also acts as the firm's Chief Financial investment Expert.
With Brown assisting the ship, Brownstone Research study is a powerhouse publisher with lots to offer its customers. After decades of constant success at the helm of top-tier companies like Tesla and Area, X, Elon Musk is a family name throughout the majority of America. If you understand even a bit about the marketplace, you understand that he has a credibility as a King Midas of sorts. white house. Whatever he touches relies on gold! Jeff is well mindful of Elon Musk's executive expertise, so he constantly has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next big project.
In truth, Brown believes S.A.V. melania trump. could be "the greatest trend of the 2020s, and he's not alone. Take a look at these quotes from other widely known S.A.V. bulls: Elon's next big act will be weding two advanced technologies: expert system and electric vehicles. Musk hopes the combination will assist him establish the first fully-autonomous, self-driving cars and trucks ever. It's nothing short of the vehicle market's Holy Grail. As you know, electric vehicles and self-driving car stocks have actually been huge this year, but the Wall Street maker has actually been big on buzz without much concrete outcome. Regardless of a drastic boost in competitors over the previous few years, Brown still believes Musk has the finest opportunity of putting everything together.
tech could be the magic string that connects everything together. S.A.V. means Shared Autonomous Lorry, and it could be the future of transportation. Essentially, this technology would permit you to lease your vehicle as an autonomous, self-driving taxi when you're not utilizing it. You just leave the vehicle and press a button on an app that informs the car to "join the fleet." Next thing you know, you're relaxing on your couch while your car shuttles ride-sharers around town. Best of all, you get to keep a large piece of the profits. It sounds outrageous, but it could be closed than you believe.